The data indicated that the expression levels of IL-17A and IL-35 in BALF were elevated during the progression of the disease in CIP patients and were positively correlated with the levels of Th1 and Tregs cells. The gene discussed is IL17A; the disease is hereditary sensory and autonomic neuropathy.